Drug intelligence / Profile preview

mepivacaine + epinephrine

Development stage: Unknown
Modality: Small Molecules
Administration: Infiltration, Nerve Block, Epidural, Caudal, Subcutaneous, Intrathecal

Overview

Mepivacaine + epinephrine is a combination local anesthetic used for dental procedures and other local or regional anesthesia. Mepivacaine is an amide-type local anesthetic that stabilizes neuronal membranes and prevents the initiation and transmission of nerve impulses, thereby producing local anesthesia. Epinephrine is added as a vasoconstrictor to promote local hemostasis, decrease systemic absorption, and increase the duration of action of the anesthetic.

Brand names: Scandonest Special
Other names: mepivacaine hydrochloride + epinephrinemepivacaine HCl + epinephrine

Targets

AR (Adrenergic receptors)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on mepivacaine + epinephrine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on mepivacaine + epinephrine.

Explore the full profile